Milliways
Milliways
Milliways
Summary
The visceral muscles of the Drosophila midgut consist of fusion occurs resulting in a complete disruption of visceral
syncytia and arise by fusion of founder and fusion- myogenesis. Subsequent characterisation of the mutations
competent myoblasts, as described for the somatic muscles. revealed that they are novel alleles of jelly belly (jeb) and
A single-step fusion results in the formation of binucleate the Drosophila Alk homologue named milliways (miliAlk).
circular midgut muscles, whereas a multiple-step fusion We show that the process of founder cell determination in
process produces the longitudinal muscles. A prerequisite the visceral mesoderm depends on Jeb signalling via the
for muscle fusion is the establishment of myoblast diversity Milliways/Alk receptor.
in the mesoderm prior to the fusion process itself. We Moreover, we demonstrate that in the somatic mesoderm
provide evidence for a role of Notch signalling during determination of the opposite cell type, the fusion-
establishment of the different cell types in the visceral competent myoblasts, also depends on Jeb and Alk,
mesoderm, demonstrating that the basic mechanism revealing different roles for Jeb signalling in specifying
underlying the segregation of somatic muscle founder myoblast diversity. This novel mechanism uncovers a
cells is also conserved during visceral founder cell crosstalk between somatic and visceral mesoderm leading
determination. not only to the determination of different cell types but also
Searching for genes involved in the determination and maintains the separation of mesodermal tissues, the
differentiation of the different visceral cell types, we somatic and splanchnic mesoderm.
identified two independent mutations causing loss of
visceral midgut muscles. In both of these mutants visceral Key words: Drosophila, Myogenesis, Visceral and Somatic muscles,
muscle founder cells are missing and the visceral mesoderm Founder cells, Fusion-competent cells, Myoblast fusion, Notch,
consists of fusion-competent myoblasts only. Thus, no Delta, lethal of scute, jelly belly, Alk, RTK signalling
of differentiation in the existing Bap-expressing visceral cytoplasmic catalytic domain (Yarden and Ullrich, 1988).
precursors. The emerging picture shows, on the one hand, Ligand binding to the extracellular domain induces activation
visceral determination genes such as tin, bap and bin, which of the kinase on the cytoplasmic side, which initiates the
are responsible for subdividing the mesoderm into different intracellular signalling. The activated RTKs phosphorylate
tissues and, on the other hand, inductive signals like Jeb, which themselves and cytoplasmic substrates, leading to activation of
promote interactions between these tissues. a number of downstream signalling molecules, and ultimately
The differentiated visceral musculature of the Drosophila induce changes in gene expression and the phenotypic state of
midgut consists of an inner layer of circular muscles and the cell (Fantl et al., 1993; van der Geer et al., 1994). RTKs
an outer layer of longitudinal muscles (Campos-Ortega thus play important roles in cellular proliferation and
and Hartenstein, 1997), the latter persisting throughout differentiation. The role of RTKs during embryonic
metamorphosis (Klapper, 2000). The founder cells of the development and especially during the determination of
longitudinal muscles have a distinct primordium at the distinct cell types has been studied in detail in Drosophila
posteriormost part of the mesoderm (Tepass and Hartenstein, (reviewed by Rebay, 2002). During specification of muscle
1994; Georgias et al., 1997; Kusch and Reuter, 1999), whereas progenitor cells from equivalent cell clusters, the Ras/MAPK
the circular visceral founder cells and all fusion-competent pathway functions as an inductive cellular determination
myoblasts (fcms) for both visceral muscle types originate from signal. This pathway is activated by both epidermal and
the trunk mesoderm (Klapper et al., 2002). Recently, it has fibroblast growth factor receptors in the dorsal embryonic
been shown that both types of visceral muscles are syncytial mesoderm [(Gabay et al., 1997); DER (Buff et al., 1998) and
and arise by fusion of founders and fcms (Klapper et al., 2001; htl (Michelson et al., 1998)], while Notch antagonises this
San Martin et al., 2001; Klapper et al., 2002). These two activity by lateral inhibition (Carmena et al., 2002). Recently,
classes of myoblasts are closely associated in a band of visceral a novel RTK named DAlk (Drosophila Anaplastic Lymphoma
precursors, which express markers such as Fasciclin III (Patel Kinase; Alk – FlyBase) was described which is expressed
et al., 1987) and are characterised by binou expression (Zaffran specifically in the developing visceral mesoderm and CNS of
et al., 2001). The ventralmost row of these visceral myoblasts Drosophila (Lorén et al., 2001). Furthermore, activation of Alk
consists of dumbfounded/kin of irre (duf/kirre)-expressing mediated signalling is required for embryonic gut development
founder cells with a characteristic columnar shape. The more and more specifically for the activation of MAP kinase in the
dorsally located fcms are characterised as such by a more visceral mesoderm (Lorén et al., 2003). As Alk drives MAPK
globular morphology and by expression of sticks and stones activation in the visceral mesoderm it is an obvious candidate
(sns). During stage 12, binucleate circular muscles are built via to be involved in determination of distinct visceral cell types.
fusion of these founders and fcms. This fusion process is In a search for genes involved in the determination of
disturbed in myoblast city (mbc), duf/kirre and sns mutants, visceral cell types, we screened a collection of EMS-induced
which are also known to be defective in somatic muscle fusion, lethal mutations established previously (Hummel et al., 1999a;
indicating that the founder cell hypothesis applies both to Hummel et al., 1999b) and identified two independent
somatic and visceral myogenesis. Thus, several of the known mutations with a nearly identical phenotype. Both exhibit a loss
genetic components are common between somatic as well as of circular visceral founder cells at early stages of visceral
visceral myoblast fusion (Klapper et al., 2001; San Martin et development, whereas fusion-competent visceral myoblasts are
al., 2001; Klapper et al., 2002). specified correctly and express markers like Fas3 and Sns. This
Differentiation of the syncytial somatic muscles depends on results in a complete absence of visceral midgut muscles.
the determination of founder and fusion-competent myoblasts Complementation analysis revealed that one mutation belongs
(Bate, 1990; Dohrmann et al., 1990). These two classes of to the previously described jelly belly (jeb) gene, while the
myoblasts are specified by lateral inhibition by the neurogenic second mutation named milliways (miliAlk) represents a Alk
genes Notch and Delta from a group of equivalent somatic allele. We describe the crucial role of these genes in the process
mesodermal cells (Carmena et al., 2002). As a consequence, of visceral founder cell determination and analyse the role of
expression of the proneural gene lethal of scute (l’sc) is Notch and Delta during the distinction between visceral cell
restricted to muscle progenitor cells. These progenitors divide types. Moreover, we uncover Jeb signalling via the Alk RTK
asymmetrically and give rise to muscle founder cells (Carmena as a new determination step for the fusion-competent cells of
et al., 1995), which are characterised by differential expression the somatic mesoderm.
of myogenic genes (reviewed by Baylies et al., 1998; Paululat
et al., 1999). After establishment of myoblast diversity, the
fusion process starts, leading in a first fusion step to muscle
Materials and methods
precursor cells and in a second fusion step to formation of Flystocks
mature myotubes (Doberstein et al., 1997; Rau et al., 2001). To find out whether Notch and Delta mutants have defects in founder
This process can be disturbed at distinct levels (reviewed cell determination in the visceral mesoderm, we used N55e11 and DlB2
by Dworak and Sink, 2002; Taylor, 2002). Besides lateral mutants from the Bloomington Drosophila Stock Center. For analysis
inhibition and determination through distinct transcription of the involvement of Notch and Delta in the founder determination
process we used a dominant-negative form of Notch [UAS-dnNotch
factors cell-cell signalling is an important mechanism in (Rebay et al., 1993; Go et al., 1998)], UAS-Notch+Delta
myogenesis. (Bloomington Drosophila Stock Center, M. Muskavitch, unpublished)
Receptor tyrosine kinases (RTKs) are involved in and UAS-Notchintra flies (Lieber et al., 1993). UAS-Notchintra allows
intercellular communication in a wide range of processes. expression of a constitutive active form of the Notch receptor.
RTKs are composed of three domains: an extracellular ligand- The collection of EMS mutagenised flies was obtained from
binding domain, a single membrane-spanning domain and a Christian Klämbt (Hummel et al., 1999a; Hummel et al., 1999b). To
Myoblast determination depends on N and Alk 745
screen for mutants with defects in the determination of founder cells myoblasts (fcms) of the somatic musculature (Carmena et al.,
in the visceral mesoderm, we stained 180 lines on the second and 270 2002). As many of the processes involved in the development
lines on the third chromosome, with anti-Fas 3 antibodies (Patel et al., of the somatic musculature also seem to affect the development
1987). We isolated a new jeb allele, jebweli and a new Alk allele, which of the visceral muscles, we investigated whether the
we named miliAlk. These two mutants were used for all experiments mechanism of determination of founder and fcms is also
described herein.
For complementation tests we used jebk05644 (Weiss et al., 2001)
conserved.
from the Bloomington Drosophila Stock Center, and Df(2R)Alk∆21 Notch and Delta play important roles in various
which is a deficiency covering 53C (Lorén et al., 2003). β- developmental processes and mutations in either gene lead to
galactosidase-expression in founder cells was achieved using the strong developmental defects during embryogenesis. Thus, it
enhancer trap line rP298-lacZ (Nose et al., 1998; Klapper et al., 2002) is difficult to analyse whether the visible defects in the visceral
and in the entire mesoderm using bap-lacZ (Azpiazu and Frasch, mesoderm are due to defects in the determination of the
1993; Zaffran et al., 2001). Overexpression studies were carried out founder cells or are a result of secondary effects. In Notch
using a bap-GAL4 driver line (Zaffran et al., 2001), which drives mutant embryos more founder cells appear to be present in the
expression in the circular visceral mesoderm from stage 10 onwards visceral mesoderm (Fig. 1A,B). The visceral fcms seem to be
or a twist-GAL4 driverline (SG24-GAL4), which drives expression in reduced compared with the wild-type expression of sticks and
the entire mesoderm (gift from A. Michelson). As UAS lines we used
UAS-Alk (Lorén et al., 2001) and UAS-jeb flies (Weiss et al., 2001).
stones (sns) as a marker for these cells (Fig. 1D,E). This
All overexpression studies were carried out at 25°C. reduction is not as severe as in the somatic mesoderm but still
quite obvious. In Delta mutants, the number of founder cells
Immunohistochemical staining also seems to be increased in comparison with the wild type
Immunostaining was performed as described previously (Knirr et al., and the fcms are reduced in mutant embryos (Fig. 1C,F).
1999; Klapper et al., 2002). The mouse Fas3 antiserum (Patel et al., These observations cannot exclude the possibility that the
1987) was used for the visualisation of the visceral mesoderm cells observed phenotypes are induced by secondary effects from
(diluted 1:5, gift from C. Klämbt). A rabbit anti-β-galactosidase defects in other tissues, among others the lack of fcms in the
antibody (Biotrend, diluted 1:2500) was used to visualise muscle somatic mesoderm. We therefore decided to perform
founder cells in the enhancer trap line rP298-lacZ and a mouse anti- overexpression studies using the UAS-GAL4 system (Brand
β-galactosidase antibody (Promega, diluted 1:500) was used to
visualise bap-lacZ expression. For analysis of the somatic mesoderm,
and Perrimon, 1993). The GAL4 and UAS lines employed here
we used rabbit anti-β3tubulin antibodies at a dilution of 1:2500 (Leiss also carry rP298-lacZ (Nose et al., 1998), which serves to mark
et al., 1988). The rabbit anti-Alk (diluted 1:500) (Lorén et al., 2003), the founder cells. As a driver line we used bap-GAL4 (Zaffran
rabbit anti-Jeb (diluted 1:100) (Weiss et al., 2001), rabbit anti-Lmd et al., 2001) to drive expression in the entire trunk visceral
(diluted 1:1000) (Duan et al., 2001), mouse anti-Notch (diluted 1:10) mesoderm. Expression of UAS-Notch+Delta, which contains
(Fuß and Hoch, 2002) and mouse anti-Delta antiserum (diluted 1:50, the entire coding regions of both genes (M. Muskavitch,
Developmental Studies Hybridoma Bank) were used in combination unpublished) or UAS-Notchintra, which represents a
with the TSA signal amplification kit (NEN). For secondary constitutively active form of Notch (Lieber et al., 1993), in the
antibodies, we used Cy2- and Cy3-labelled antibodies made in goat visceral mesoderm, both result in a distinct phenotype. In
against rabbit and mouse from Dianova (diluted 1:40 and 1:100). The midgut preparations of these embryos the founder cells of the
embryos were embedded in Fluoromount G (Southern Biotechnology
Associates) and photos were taken under Nomarski optics with a Zeiss
circular visceral mesoderm are strongly reduced (Fig. 1K,L;
Axiophot microscope or a Leitz confocal microscope and processed data not shown for UAS-Notch+Delta) and later on, no
with Adobe Photoshop 6.0 (Adobe Systems). functional visceral mesoderm can be observed (data not
shown). By contrast, the founder cells of the longitudinal
In situ hybridisation visceral muscles, which have a different origin at the posterior
In order to visualise fcms in the mesoderm, whole-mount fluorescent tip of the embryo are still present (arrowheads in Fig. 1K,L).
DNA hybridisation was performed with random digoxigenin-labelled Interestingly, bap-GAL4-driven expression of the Notch ligand
sticks and stones cDNA probes according to Knirr et al. (Knirr et al., Delta does not result in fewer founder cells in the visceral
1999). The sns cDNA was a gift from S. Abmayr (Bour et al., 2000). mesoderm (data not shown).
For the combination with antibody stainings to visualise β- To exclude the possibility that the described defects are due
galactosidase expression we used anti-β-galactosidase antiserum
(Cappel) at a dilution of 1:3000.
to non-endogenous effects induced by the overexpression of
the examined genes in the wrong tissue, we analysed wild-type
Lethal phase analysis Notch expression and found that it is indeed expressed in the
To test the lethality of the progeny from UAS-GAL4 crosses we mated visceral mesoderm. Notch is localised at cell membranes in the
homozygous lines carrying the founder cell marker rP298-lacZ, entire visceral mesoderm during stage 11, with expression
collected eggs for 24 hours and allowed further development for becoming weaker in the fcms of the visceral mesoderm, which
another 48 hours at 25°C. Afterwards, we counted at least 1000 continue to express bap-lacZ after the determination process is
progeny of each cross. finished (Fig. 1G,H, arrowhead in G). This reduction of Notch
expression in the fcms after the establishment of the founder
Results and discussion cells is similar to its expression in the somatic mesoderm,
where Notch expression is also highest in the progenitor cell
Founder cell determination in the visceral after the determination process is completed (Carmena et al.,
mesoderm depends upon Notch 2002). Surprisingly, the analysis of Delta expression exhibits
The process of lateral inhibition involving Notch and its ligand that this Notch ligand is not expressed in the visceral mesoderm
Delta, which was first discovered in the nervous system, also during founder cell formation. Delta expression was found
plays a role in determining the founder and fusion-competent in adjacent, probably somatic cells (Fig. 1I,J) and might be
746 Development 131 (4) Research article
mutants (Fig. 5B). Therefore the RTK signalling pathway Having found that sns is no longer expressed in the fcms
involving Jeb and Alk is not only needed for founder cell of the somatic mesoderm, we decided to look at the
specification of the visceral mesoderm but also for the transcription factor lame duck/myoblast incompetent/gleeful
differentiation of the fcms in the somatic mesoderm. (lmd/minc/glee), which is expressed in the somatic and visceral
fcms and is responsible for their
determination (Duan et al., 2001; Furlong
et al., 2001; Ruiz-Gómez et al., 2002).
The expression pattern of Lmd in the wild
type is similar to that of sns and the
protein is present in two bands in stage
11-12 (Fig. 5G). In both jebweli and miliAlk
mutants, the Lmd expression pattern is
present (Fig. 5H,I) not only in the fcms of
the visceral mesoderm but also in the
somatic ones, even though it seems as if
it is slightly weaker in the ventral part in
the mutants than in the wild type. These
data suggest that in jebweli and miliAlk
mutants the initial determination of the
fcms in the somatic mesoderm takes
place, but the subsequent differentiation
is blocked. Therefore, the Alk-RTK
signalling pathway in the somatic
mesoderm seems to be essential for the
Fig. 5. The fusion-competent myoblasts of the somatic mesoderm do not differentiate in differentiation of the fcms but not for the
jebweli and miliAlk mutants. (A-C) sns in situ hybridisation of stage 11 embryos marks fcms initial determination.
in the visceral and somatic mesoderm. In wild-type embryos, sns is expressed in two bands
along the entire length of the embryo (A). These bands are connected in a ladder-like The fusion-competent myoblasts
pattern, where the ventral band represents the fcms of the somatic mesoderm (arrow in A), of the visceral mesoderm become
and the dorsal band consists of the fcms of the visceral mesoderm (arrowhead in A). In incorporated into the somatic
jebweli (B) and miliAlk (C) mutant embryos, the fcms of the visceral mesoderm and some mesoderm
cells that connect the two bands are present (arrowheads); however, the ventral band of fcms Because most of the fcms of the somatic
of the somatic mesoderm shows no sns expression. (D-F) Alk (green) and Fas3 expression
(red) in stage 11 wild-type embryos. In addition to expression in the visceral mesoderm, Alk
mesoderm are not expressing sns in jebweli
is also transiently expressed in some cells in the neuroectoderm and in patches in the and miliAlk mutants, we had a closer look
somatic mesoderm (arrows in D,F). (G-I) Lmd expression of stage 12 embryos. In the wild at defects in this tissue. β-galactosidase
type, Lmd is expressed in two bands in the fcms of the somatic and visceral mesoderm (G). antibody staining in mutants carrying the
In jebweli (H) and miliAlk (I) mutants, expression in both mesodermal cell types can be founder cell marker rP298-lacZ show a
observed. regular pattern of somatic founder cells
compared with the wild type in the
somatic mesoderm (Fig. 4J-L). Only in
some of the mutant embryos could we
detect local distortions because the
defects in the visceral mesoderm (data not
shown). β3tubulin antibody staining
(Leiss et al., 1988) shows some mild
fusion defects in the dorsal and ventral
muscles in jebweli and miliAlk mutants
indicated by unfused myoblasts in this
region and long thin projections of the
muscles (Fig. 6B,C, compare with A).
The development of the visceral
mesodermal cells cannot be followed with
Fas3 staining because it disappears in the
Fig. 6. The cells of the visceral mesoderm of jebweli and miliAlk mutants become mutants after stage 11. Therefore, we
incorporated in the somatic musculature. Ventrolateral (A,B,C) muscles of stage 16 embryos visualised the fate of the fcms using the
as visualised by β3tubulin expression (green in A-F). Cells of the visceral mesoderm are
marked by bap-lacZ expression (red in D-F). Compared with the wild type (A) the somatic
visceral mesoderm marker bap-lacZ,
muscles in both jebweli and miliAlk mutants are thinner and show long thin projections (B,C; which normally is expressed exclusively
arrow in B). Several unfused myoblasts are visible (arrow in C). (D-F) In wild-type in the visceral mesoderm throughout
embryos, no bap-lacZ expression is found in the somatic mesoderm during all stages of embryonic development (Azpiazu and
development (stage 14, D). By contrast, jebweli and miliAlk mutant embryos exhibit bap-lacZ Frasch, 1993; Zaffran et al., 2001) (Fig.
expression in the lateral muscles of the somatic mesoderm (stage 14, E,F). 6D). We observe that jebweli and miliAlk
750 Development 131 (4) Research article
mutants carrying this marker show β-galactosidase expression whereas the others develop into fcms. Staining with anti-Alk
in the somatic mesoderm from late stage 12 onwards (Fig. antibodies (Lorén et al., 2003) show that in the wild type the
6E,F). protein is localised at the cell membranes in the visceral
From previous studies, it is known that a lack of sns mesoderm (Fig. 7A). Surprisingly, Alk can be found in the
expression in fcms in the somatic mesoderm results in strong founder cells of the circular visceral muscles and in the fusion-
defects in the somatic musculature where the founder cells competent myoblasts (Fig. 7A-C), which are not obviously
become blocked at the point of myoblast fusion (Bour et al., affected in miliAlk mutants (Fig. 4C,F).
2000). Because we are not able to detect such a strong In jebweli mutants, the localisation of Alk is not affected.
phenotype in miliAlk and jebweli mutants, and together with the Identical to the wild type, it localises at the cell membranes
fact that bap-lacZ-expressing cells are present in the somatic and is also present in all cells of the visceral mesoderm, which
mesoderm, we conclude that the sns-expressing cells from the persist in these mutants (Fig. 7D-F). In miliAlk mutant embryos,
visceral mesoderm now become incorporated into the somatic however, the Alk protein is still detectable in all cells of the
mesoderm and replace at least a fraction of the somatic fcms. visceral mesoderm, but it is not correctly localised at the cell
membrane and is instead found in the cytoplasm (Fig. 7G-I).
Alk protein is mislocalised in milliwaysAlk mutant Because of this mislocalisation and the fact that the embryos
embryos and co-localises with Jeb at the transheterozygous for Df(2R)Alk∆21 and miliAlk display the
membranes of visceral founder cells same phenotype in the visceral mesoderm as the miliAlk mutant
As jeb is a secreted protein we were interested whether the embryos alone (data not shown), we conclude that the mutation
localisation of Alk controls the specification for the more is a phenotypic null allele even though at least the N-terminal
ventral cells of the visceral mesoderm to become founder cells part of the protein, against which the antibody is raised, is still
present. As the Alk receptor is not properly
localised, the founder cells cannot receive
the Jeb signal and thus the signal
transduction pathway leading to the
activation of duf/kirre in the visceral
founders is disturbed.
As Alk is localised at the membranes of
all visceral cells and not only in the
founder cells, we reasoned that the
localisation of the Jeb protein must be
responsible for the activation of the RTK
pathway only in visceral founder cells.
Therefore we postulate a co-localisation
of both proteins only at the
prospective founder cells. The double
immunolabelling with Jeb (Weiss et al.,
2001) and Alk (Loren et al., 2003)
antibodies demonstrates that Jeb protein
only co-localises at the membranes of the
visceral founder cells with the Alk protein
(Fig. 7J,K). Moreover, this specific
interaction cannot be found in miliAlk
mutants where, owing to the mis-
localisation of the receptor protein, no Jeb
uptake takes place (Fig. 7L,M). Therefore
these mutants display an inactive RTK
pathway.
mesoderm display an active RTK pathway as a result of this visceral muscles that later on encircle the midgut. This ability
interaction and later become the founders of the visceral to form muscles is one of the characteristics of founder cells.
mesoderm could be explained by the fact that these cells are From sns and mbc mutants, it is known that even though no
closest to the cells that secrete the Jeb signal (Fig. 7K), which fusions take place, mini-muscles are formed in the somatic
we suggest is the limiting factor. We therefore set out to test mesoderm that display the right orientation and attachment
whether increased levels of Jeb can change the fate of the more sites (Rushton et al., 1995; Bour et al., 2000). This has also
dorsally located visceral fcms, which also express the receptor been shown for the founder cells of the visceral mesoderm. In
Alk, to become founder cells. We again used the UAS-GAL4 sns mutants, apart from the first gut constriction the visceral
system and expressed UAS-jeb in the entire mesoderm with a mesoderm develops normally (Bour et al., 2000). On closer
twi-GAL4 driver. As expected, nearly all cells of the visceral inspection just the founder cells differentiate, whereas the fcms
mesoderm are now converted to founder cells (Fig. 8A,B). remain undifferentiated (Klapper et al., 2002). Thus, apart from
Even though fcms are missing, the founders are able to form the increased number of founder cells no defects are visible.
The same phenotype can be observed if
UAS-jeb is ectopically expressed only in
the visceral mesoderm (data not shown).
sns in situ hybridisation confirms that
through the overexpression of UAS-jeb in
either the entire or just the visceral
mesoderm, the fate of the fcms is changed
so that they no longer express fcms-
specific gene products such as SNS. This
seems to be the reason why the band of
fcms of the visceral mesoderm (Fig. 8D)
is missing in these embryos (Fig. 8E). The
somatic mesoderm (Fig. 8G) shows no
defects as indicated by an anti-β3tubulin
staining (Fig. 8H). Overexpression of
UAS-jeb in a Alk mutant background
shows that the UAS-jeb overexpression
phenotype is suppressed in the Alk
mutants (data not shown). Therefore jeb
is dependent upon Alk as a receptor
to activate the downstream signalling
pathway.
In the wild type, the limited amount of
the Jeb signal appears to restrict founder
cell determination to the most ventral
cells of the visceral mesoderm (Fig. 9).
However, these findings prove that in
principle all cells of the visceral
mesoderm are able to respond to jeb
signalling. Furthermore, we found no
Fig. 8. Ectopic expression of UAS-Alk and UAS-jeb in the mesoderm gives rise to different difference when the signal is produced
phenotypes. Wild-type embryos are shown in A,D,G and L. (B,E,H) UAS-jeb is ectopically from the somatic or the visceral
expressed with a twi-GAL4 driverline. (C,F,I,J,K,M) UAS-Alk is ectopically expressed with mesoderm.
a twi-GAL4 (C,F,I,M) or bap-GAL4 driver line (J,K). Founder cells (f) are marked by
rP298-lacZ expression (green in A,B,J,K). (D-F) Fusion-competent myoblasts (fcms) are Ectopic expression of UAS-Alk
visualised by sns in situ hybridisation. (B) Ectopic expression of UAS-jeb converts all cells
of the visceral mesoderm to founder cells. (E) sns expression is absent in these cells of the
gives a similar phenotype as in
visceral mesoderm. (H) The somatic mesoderm shows no defects, as indicated by β3tubulin miliAlk and jebweli mutants
antibody staining. (C) No visceral founder cells can be detected by Fas3 staining of stage Anti-Alk stainings on embryos carrying
11 embryos in which UAS-Alk is ectopically expressed in the entire mesoderm. (F) sns in the visceral mesoderm marker bap-lacZ
situ hybridisation indicates that through the overexpression of UAS-Alk the fcms of the show that Alk is expressed in all cells
somatic mesoderm are missing in stage 11 and only the band of the fcms of the visceral of the visceral mesoderm, some
mesoderm remains. (I) The dorsal and ventral somatic muscles in stage 16 show a fusion neuroectodermal cells and transiently in
defect phenotype with thin projections (arrow) and unfused myoblasts (arrowhead) as stage 10 to 11 in cell clusters in the
indicated by β3tubulin staining. When UAS-Alk is expressed only in the visceral mesoderm
with a bap-GAL4 driverline, which also carries rP298-lacZ as founder cell marker, the
somatic mesoderm (Fig. 5D-F, Fig. 9). We
founder cells of the visceral mesoderm are still present and seem to be doubled in number were interested in the consequences of
(J,K). In contrast to a single row in the wild type (A), a second row of founder cells is ectopic expression of UAS-Alk in the
present in these stage 11 embryos. The bands of both halves of the embryo are shown (J,K). entire mesoderm. Surprisingly, the
In the wild type, jeb is expressed in a continuous band in the mesoderm (L), whereas upon overexpression of UAS-Alk by a twi-GAL4
overexpression of UAS-Alk in the entire mesoderm the signal is reduced (M). driver produces a similar phenotype to
752 Development 131 (4) Research article
that in miliAlk or jebweli mutant embryos. In early stage 11 only We are grateful to Christian Klämbt for sharing fly stocks and
fcms are visible in Fas3 stainings (Fig. 8C) and later on there results prior to publication. We thank Peter Seum for excellent
is no evidence of the presence of visceral mesoderm any more. technical assistance. We are indebted to Simone Lier, Henning Mootz
and Christian Klämbt for critical reading of the manuscript and
In the somatic mesoderm, defects can be seen by an anti-
helpful comments. We thank the Bloomington Stock Center for fly
β3tubulin antibody staining (Fig. 8I). Several muscles are small stocks, Christian Klämbt for Fas3 antibody, Manfred Frasch for bap-
and display a spindle-like shape with long and thin projections, GAL4 and bap-lacZ, Joe Weiss for UAS-jeb flies and Jeb-antibody,
indicating that only few myoblasts fuse to form the muscles. Thomas Klein for UAS-Nintra flies, Dieter Maier for UAS-dnNotch
In comparison with jebweli and miliAlk mutants (Fig. 6B,C), in flies, Hanh Nguyen for Lmd-antibodies, Alan Michelson for SG24-
the Alk overexpressing embryos the muscle defects are GAL4 flies, Akinao Nose for rP298-lacZ, and Susan Abmayr for the
Myoblast determination depends on N and Alk 753
generous gift of sns cDNA. This work was supported by the Deutsche subdivision of trunk visceral mesoderm parasegments in Drosophila is
Forschungsgemeinschaft to R.R.-P. (Re 628/10-3 and 10-4) as well as required for gut and trachea development. Development 130, 439-449.
the Kerckhoff-Stiftung and the Fonds der Chemischen Industrie to Hummel, T., Schimmelpfeng, K. and Klämbt, C. (1999a). Commissure
R.R.-P., and by a Landesgraduiertenstipendium nach dem Hessischen formation in the embryonic CNS of Drosophila. Dev. Biol. 209, 381-398.
Gesetz zur Förderung von Nachwuchswissenschaftlern to C.S. Hummel, T., Schimmelpfeng, K. and Klämbt, C. (1999b). Commissure
formation in the embryonic CNS of Drosophila. Development 126, 771-
779.
Klapper, R. (2000). The longitudinal musculature of Drosophila melanogaster
References persists through metamorphosis. Mech. Dev. 95, 47-54.
Anderson, K. V. (1998). Pinning down positional information: dorsal-ventral Klapper, R., Heuser, S., Strasser, T. and Janning, W. (2001). A new
polarity in the Drosophila embryo. Cell 95, 439-442. approach reveals syncytia within the visceral musculature of Drosophila
Azpiazu, N. and Frasch, M. (1993). tinman and bagpipe: two homeobox melanogaster. Development 128, 2517-2524.
genes that determine cell fates in the dorsal mesoderm of Drosophila. Genes Klapper, R., Stute, C., Schomaker, O., Strasser, T., Janning, W.,
Dev. 7, 1325-1340. Renkawitz-Pohl, R. and Holz, A. (2002). The formation of syncytia within
Azpiazu, N., Lawrence, P. A., Vincent, J. P. and Frasch, M. (1996). the visceral musculature of the Drosophila midgut is dependent on duf, sns
Segmentation and specification of the Drosophila mesoderm. Genes Dev. and mbc. Mech. Dev. 110, 85-96.
10, 3183-3194. Knirr, S., Azpiazu, N. and Frasch, M. (1999). The role of the NK-homeobox
Bate, M. (1990). The embryonic development of larval muscles in Drosophila. gene slouch (S59) in somatic muscle patterning. Development 126, 4525-
Development 110, 791-804. 4535.
Baylies, M. K., Bate, M. and Ruiz-Gómez, M. (1998). Myogenesis: a view Kusch, T. and Reuter, R. (1999). Functions for Drosophila brachyenteron and
from Drosophila. Cell 93, 921-927. forkhead in mesoderm specification and cell signalling. Development 126,
Bodmer, R. (1993). The gene tinman is required for specification of the heart 3991-4003.
and visceral muscles in Drosophila. Development 118, 719-729. Leiss, D., Hinz, U., Gasch, A., Mertz, R. and Renkawitz-Pohl, R.
Borkowski, M., Brown, N. H. and Bate, M. (1995). Anterior-posterior (1988). Differentiation of mesodermal derivatives during Drosophila
subdivision and the diversification of the mesoderm in Drosophila. embryogenesis is characterized by β3 tubulin expression. Development
Development 121, 4183-4193. 104, 525-531.
Bour, B. A., Chakravarti, M., West, J. M. and Abmayr, S. M., (2000). Lieber, T., Kidd, S., Alcamo, E., Corbin, V. and Young, M. W. (1993).
Drosophila SNS, a member of the immunoglobulin superfamily that is Antineurogenic phenotypes induced by truncated Notch proteins indicate a
essential for myoblast fusion. Genes Dev. 14, 1498-1511. role in signal transduction and may point to a novel function for Notch in
Brand, A. H. and Perrimon, N. (1993). Targeted gene expression as a means nuclei. Genes Dev. 7, 1949-1965.
of altering cell fates and generating dominant phenotypes. Development 118, Lorén, C. E., Scully, A., Grabbe, C., Edeen, P. T., Thomas, J., McKeown,
401-415. M., Hunter, T. and Palmer, R. H. (2001). Identification and
Buff, E., Carmena, A., Gisselbrecht, S., Jimenez, F. and Michelson, A. M. charakterization of DAlk: a novel Drosophila melanogaster RTK which
(1998). Signalling by the Drosophila epidermal growth factor is required for drives ERK activation in vivo. Genes Cells 6, 531-544.
the specification and diversification of embryonic muscle progenitors. Lorén, C. E., Englund, C., Grabbe, C., Hallberg, B., Hunter, T. and
Development 125, 2075-2086. Palmer, R. H. (2003). A crucial role for the Anaplastic lymphoma kinase
Campos-Ortega, J. A. and Hartenstein, V. (1997). The Embryonic receptor tyrosine kinase in gut development in Drosophila melanogaster.
Development of Drosophila melanogaster. Berlin: Springer-Verlag. EMBO Rep. 4, 781-786.
Carmena, A., Bate, M. and Jimenez, F. (1995). lethal of scute, a proneural Michelson, A. M., Gisselbrecht, S., Zhou, Y., Baek, K. H. and Buff, E. M.
gene, participates in the specification of muscle progenitors during (1998). Dual functions of the heartless fibroblast growth factor in
Drosophila embryogenesis. Genes Dev. 9, 2373-2383. development of the Drosophila embryonic mesoderm. Dev. Genet. 22, 212-
Carmena, A., Buff, E., Halfon, M. S., Gisselbrecht, S., Jimenez, F., Baylies, 229.
M. K. and Michelson, A. M. (2002). Reciprocal regulatory interactions Nose, A., Isshiki, T. and Takeichi, M. (1998). Regional specification of
between the Notch and Ras signalling pathways in the Drosophila muscle progenitors in Drosophila: the role of the msh homeobox gene.
embryonic mesoderm. Dev. Biol. 244, 226-242. Development 125, 215-223.
Dohrmann, C., Azpiazu, N. and Frasch, M. (1990). A new Drosophila Patel, N. H., Snow, P. M. and Goodman, C. S. (1987). Characterization and
homeobox gene is expressed in mesodermal precursor cells of distinct cloning of Fasciclin III: A glycoprotein expressed on a subset of neurons
muscles during embryogenesis. Genes Dev. 4, 2098-2111. and axon pathways in Drosophila. Cell 48, 975-988.
Doberstein, S. K., Fetter, R. D., Mehta, A. Y. and Goodman, C. S. (1997). Paululat, A., Holz, A. and Renkawitz-Pohl, R. (1999). Essential genes for
Genetic analysis of myoblast fusion: blown fuse is required for progression myoblast fusion in Drosophila embryogenesis. Mech. Dev. 83, 17-26.
beyond the prefusion complex. J. Cell Biol. 136, 1249-1261. Rau, A., Buttgereit, D., Holz, A., Fetter, R., Doberstein, S. K., Paululat,
Duan, H., Skeath, J. B. and Nguyen, H. T. (2001). Drosophila Lame duck, A., Staudt, N., Skeath, J., Michelson, A. M. and Renkawitz-Pohl,
a novel member of the Gli superfamily, acts as a key regulator of myogenesis R. (2001). rolling pebbles (rols) is required in Drosophila muscle
by controlling fusion-competent myoblast development. Development 128, precursors for recruitment of myoblasts for fusion. Development 128,
4489-4500. 5061-5073.
Dworak, H. A. and Sink, H. (2002). Myoblast fusion in Drosophila. Rebay, I. (2002). Keeping the receptor tyrosine kinase signaling pathway in
BioEssays 24, 591-601. check: lessons from Drosophila. Dev. Biol. 251, 1-17.
Fantl, W. J., Johnson, D. E. and Williams, L. T. (1993). Signalling by Rebay, I., Fehon, R. G. and Artavanis-Tsakonas, S. (1993). Specific
receptor tyrosine kinases. Annu. Rev. Biochem. 62, 453-481. truncation of Drosophila Notch define dominant activated and dominant
Furlong, E. E., Andersen, E. C., Null, B., White, K. P. and Scott, M. P. negative forms of the receptor. Cell 74, 319-329.
(2001). Patterns of gene expression during Drosophila mesoderm Riechmann, V., Irion, U., Wilson, R., Grosskortenhaus, R. and Leptin, M.
development. Science 297, 1629-1633. (1997). Control of cell fates and segmentation in the Drosophila mesoderm.
Fuß, B. and Hoch, M. (2002). Notch signaling controls cell fate Development 124, 2915-2922.
specification along the dorsoventral axis of the Drosophila gut. Curr. Biol. Ruiz-Gómez, M., Coutts, N., Price, A., Taylor, M. V. and Bate, M. (2000).
12, 171-179. Drosophila Dumbfounded: a myoblast attractant essential for fusion. Cell
Gabay, L., Seger, R. and Shilo, B. Z. (1997). MAP kinase in situ activation 102, 189-198.
atlas during Drosophila embryogenesis. Development 124, 3535-3541. Ruiz-Gómez, M., Coutts, N., Suster, M. L., Landgraf, M. and Bate, M.
Georgias, C., Wasser, M. and Hinz, U. (1997). A basic-helix-loop-helix (2002). myoblasts incompetent encodes a zinc finger transcription factor
protein expressed in precursors of Drosophila longitudinal visceral muscles. required to specify fusion-competent myoblasts in Drosophila. Development
Mech. Dev. 69, 115-124. 129, 189-198.
Go, M. J., Eastman, D. S. and Artavanis-Tsakonas, S. (1998). Cell Rushton, E., Drysdale, R., Abmayr, S. M., Michelson, A. M. and Bate, M.
proliferation control by Notch signalling in Drosophila development. (1995). Mutations in a novel gene, myoblast city, provide evidence in
Development 125, 2031-2040. support of the founder cell hypothesis for Drosophila muscle development.
Hosono, C., Takaira, K., Matsuda, R. and Saigo, K. (2003). Functional Development 121, 1979-1988.
754 Development 131 (4) Research article
San Martin, B., Ruiz-Gómez, M., Landgraf, M. and Bate, M. (2001). A van der Geer, P., Hunter, T. and Lindberg, R. A. (1994). Receptor protein-
distinct set of founders and fusion-competent myoblasts make visceral tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell
muscles in the Drosophila embryo. Development 128, 3331-3338. Biol. 10, 251-337.
Strünkelnberg, M., Bonengel, B., Moda, L. M., Hertenstein, A., de Couet, Weiss, J., Suyama, K. L., Lee, H. and Scott, M. P. (2001). Jelly belly: a
H. G., Ramos, R. G. and Fischbach, K. F. (2001). rst and ist paralogue Drosophila LDL receptor repeat-containing signal required for mesoderm
kirre act redundantly during embryonic muscle development in Drosophila. migration and differentiation. Cell 107, 387-398.
Development 128, 4229-4239. Yarden, Y. and Ullrich, A. (1988). Molecular analysis of signal transduction
Taylor, M. (2002). Drosophila development: novel signal elicits visceral by growth factors. Biochemistry 27, 3113-3119.
response. Curr. Biol. 12, R102-R104. Zaffran, S., Küchler, A., Lee, H. and Frasch, M. (2001). biniou (FoxF), a
Tepass, U. and Hartenstein, V. (1994). Epithelium formation in the central component in a regulatory network controlling visceral mesoderm
Drosophila midgut depends on the interaction of endoderm and mesoderm. development and midgut morphogenesis in Drosophila. Genes Dev. 15,
Development 120, 579-590. 2900-2915.